Overview
Recent release of three major health surveys – NFHS‑6, the NSO 80th round Household Consumption on Health and the National Health Accounts (2022‑23) – were meant to give a national health stock‑take. Instead, the data have been under‑used, and policy response has been weak.
Key Developments
- Media highlighted rising obesity, diabetes and hypertension, but these trends were already known.
- Industry used the findings to promote weight‑loss products, diagnostic kits and private clinics.
- Only the two reports on health expenditure received little public attention.
- Data collection for NFHS‑6 took place in 2023‑24, but public debate began only in mid‑2026, creating a three‑year lag.
- Raw survey files are released late, delaying academic analysis by 3‑5 years.
Important Facts
• Obesity and other NCDs have spread from urban affluent groups to all socio‑economic sections.
• Out‑of‑pocket expenditure (OOPE) on medicines remains high, indicating weak public drug procurement.
• Child anaemia shows no improvement, yet reports only note it without corrective action.
• The lag between data collection (2023‑24) and public discussion (2026) allows governments to cherry‑pick positive indicators and dismiss negative ones as “old data”.
Exam Relevance
Understanding how health data translate into policy is essential for GS3 questions on health financing, public‑health programmes and data‑driven governance. The article also touches on GS4 themes such as accountability, transparency and evidence‑based policymaking.
Way Forward
- Publish an action note within 30‑45 days of each survey, jointly prepared by the government and independent academics, highlighting improvements, stagnations and deteriorations, and assigning responsibility.
- Conduct regular state‑level health data review meetings with health secretaries, financ